Catalyst Wire Dossier Catalyst Wire Dossier

TFH-targeting genetic vaccine strategy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TFH-targeting genetic vaccine strategy, covering 2025-10-31 to 2025-10-31. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses [Phase 1, Phase 2]

See pricing